Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy.
Gosseaume C, Fournier T, Jéru I, Vignaud ML, Missotte I, Archambeaud F, Debussche X, Droumaguet C, Fève B, Grillot S, Guerci B, Hieronimus S, Horsmans Y, Nobécourt E, Pienkowski C, Poitou C, Thissen JP, Lascols O, Degrelle S, Tsatsaris V, Vigouroux C, Vatier C. Gosseaume C, et al. Among authors: archambeaud f. Eur J Endocrinol. 2023 Mar 2;188(3):lvad023. doi: 10.1093/ejendo/lvad023. Eur J Endocrinol. 2023. PMID: 36806620
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network.
Mosbah H, Vantyghem MC, Nobécourt E, Andreelli F, Archambeaud F, Bismuth E, Briet C, Cartigny M, Chevalier B, Donadille B, Daguenel A, Fichet M, Gautier JF, Janmaat S, Jéru I, Legagneur C, Leguier L, Maitre J, Mongeois E, Poitou C, Renard E, Reznik Y, Spiteri A, Travert F, Vergès B, Zammouri J, Vigouroux C, Vatier C. Mosbah H, et al. Among authors: archambeaud f. Diabetes Obes Metab. 2022 Aug;24(8):1565-1577. doi: 10.1111/dom.14726. Epub 2022 May 12. Diabetes Obes Metab. 2022. PMID: 35445532 Free PMC article.
[Muscular weakness and weight loss in à 44 year-old man].
Mas R, Magy L, Jésus P, Ly K, Archambeaud F, Gondran G. Mas R, et al. Among authors: archambeaud f. Rev Med Interne. 2021 Dec;42(12):887-890. doi: 10.1016/j.revmed.2021.10.007. Epub 2021 Nov 12. Rev Med Interne. 2021. PMID: 34776277 French. No abstract available.
French Endocrine Society Guidance on endocrine side effects of immunotherapy.
Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F. Castinetti F, et al. Among authors: archambeaud f. Endocr Relat Cancer. 2019 Feb;26(2):G1-G18. doi: 10.1530/ERC-18-0320. Endocr Relat Cancer. 2019. PMID: 30400055 Free PMC article.
Expert opinion on the metabolic complications of mTOR inhibitors.
Bouillet B, Buffier P, Smati S, Archambeaud F, Cariou B, Vergès B. Bouillet B, et al. Among authors: archambeaud f. Ann Endocrinol (Paris). 2018 Oct;79(5):583-590. doi: 10.1016/j.ando.2018.07.010. Epub 2018 Aug 23. Ann Endocrinol (Paris). 2018. PMID: 30144939 Review.
Expert opinion on immunotherapy induced diabetes.
Smati S, Buffier P, Bouillet B, Archambeaud F, Vergès B, Cariou B. Smati S, et al. Among authors: archambeaud f. Ann Endocrinol (Paris). 2018 Oct;79(5):545-549. doi: 10.1016/j.ando.2018.07.006. Epub 2018 Jul 25. Ann Endocrinol (Paris). 2018. PMID: 30126628 Review.
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.
Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F. Castinetti F, et al. Among authors: archambeaud f. Ann Endocrinol (Paris). 2018 Oct;79(5):591-595. doi: 10.1016/j.ando.2018.07.005. Epub 2018 Jul 11. Ann Endocrinol (Paris). 2018. PMID: 30056975 Review.
42 results